(i) Assessing ONB (named ONB-CFTR) to be performed using an air-liquid interface model of airway epithelium, developed from nasal cells of patients, without or with a combination of existing CFTR modulators, depending on the patient’ genotype(ii) Building a local biobank of rectal organoids from CF patients. Here, CFTR is linked to cystic fibrosis.